1BEY | H:1-121 | ANTIBODY TO CAMPATH-1H HUMANIZED FAB |
1BFO | B:1-121; D:1-121; F:1-121; H:1-121 | CAMPATH-1G IGG2B RAT MONOCLONAL FAB |
1C5D | B:1-117; H:1-117 | THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A RAT MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR |
1CE1 | H:1-121 | 1.9A STRUCTURE OF THE THERAPEUTIC ANTIBODY CAMPATH-1H FAB IN COMPLEX WITH A SYNTHETIC PEPTIDE ANTIGEN |
1F3R | B:1-123 | COMPLEX BETWEEN FV ANTIBODY FRAGMENT AND AN ANALOGUE OF THE MAIN IMMUNOGENIC REGION OF THE ACETYLCHOLINE RECEPTOR |
1FN4 | B:1-106; D:1-106 | CRYSTAL STRUCTURE OF FAB198, AN EFFICIENT PROTECTOR OF ACETYLCHOLINE RECEPTOR AGAINST MYASTHENOGENIC ANTIBODIES |
1LK3 | H:1-119; I:1-119 | ENGINEERED HUMAN INTERLEUKIN-10 MONOMER COMPLEXED TO 9D7 FAB FRAGMENT |
1OAQ | H: | FREE CONFORMATION AB1 OF THE IGE SPE-7 |
1OAR | H:; J:; K:; I: | FV IGE SPE-7 IN COMPLEX WITH ALIZARIN RED |
1OAU | H:; I:; J:; K: | FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH DNP-SER (IMMUNISING HAPTEN) |
1OAX | H:; J: | FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH ACENAPHTHENEQUINONE |
1OAY | H:; J: | ANTIBODY MULTISPECIFICITY MEDIATED BY CONFORMATIONAL DIVERSITY |
1OAZ | H:; J: | IGE FV SPE7 COMPLEXED WITH A RECOMBINANT THIOREDOXIN |
1OCW | H: | FREE CONFORMATION AB2 OF THE IGE SPE-7 |
2ARJ | B:1-113; H:1-113 | CD8ALPHA-ALPHA IN COMPLEX WITH YTS 105.18 FAB |
2BJM | H: | SPE7:ANTHRONE COMPLEX |